Trump Administration Salutes Parade Of Generic Drug Approvals, But Hundreds Aren’t For Sale
(By Sydney Lupkin and Jay Hancock for Kaiser Health News) The Trump administration has been trumpeting a huge increase in
Read More
FDA
FDA releases regulatory framework for digital health: 4 things to know
(By Jessica Kim Cohen for Becker’s Hospital Review) The FDA has drafted a new regulatory framework outlining how it wants to
Read MoreGottlieb blasts high insulin prices, touts far-off new rules he says will spur competition in that market
(By Nicholas Florko for STAT) WASHINGTON — FDA Commissioner Scott Gottlieb blasted insulin makers Tuesday for what he called unacceptably
Read MoreGovernment Investigation Finds Flaws In the FDA’s Orphan Drug Program
(By Sarah Jane Tribble and Sydney Lupkin for Kaiser Health News) The Food and Drug Administration has failed to ensure
Read MoreIntensity, duration of drug shortages are spiking, FDA says
(By Alia Paavola for Becker’s Hospital Review) The FDA is not only seeing an increased incidence of drug shortages, there’s
Read More‘A loss for the rest of us’: An FDA approval is a boon for a drug maker, but could come at a major cost for patients
(By Meghana Keshavan for STAT) Vickie Moored can walk again. Her words don’t slur, her vision isn’t blurred, and she
Read MoreFDA Seeks Ban On Menthol Cigarettes To Fight Teen Smoking
(By Rob Stein for NPR) The Food and Drug Administration announced Thursday that it will seek a ban on the
Read MoreNovartis gives up on FDA clearance for its biosimilar: 5 notes
(By Alia Paavola for Becker’s Hospital Review) Novartis will stop working toward FDA approval for its biosimilar of rituximab, a
Read MoreRailing against ‘global freeloading,’ Trump details new plan to lower drug prices
(By Ike Swetlitz for STAT) WASHINGTON — President Trump on Thursday blasted pharmaceutical companies for having “rigged the system” against
Read MoreHospital-owned drug company doesn’t want special treatment in Washington, exec says
(By Alia Paavola for Becker’s Hospital Review) An executive of the new hospital-owned drug company Civica Rx said he and
Read More